Sort
78,016 grants matching “breast cancer”
Regulation of resistance to CDK4/6 inhibitor in breast cancer
$633,959Wenge Zhu · George Washington University · R01 · FY2025 · CA
Integrated PET+DBT for optimization of breast cancer therapy
$633,934Paul E Kinahan · University Of Washington · U01 · FY2025 · EB
Comparative Effectiveness of Interventions to Improve Screening Among Rural Women
$633,922Electra D. Paskett · Ohio State University · R01 · FY2017 · CA
Early Detection and Diagnosis of Lung Cancer with Endomicroscopy
$633,891Melissa J Suter · Massachusetts General Hospital · R01 · FY2022 · CA
Reversing Drug Resistance in Tumors with Clickable Antibody Pairs
$633,832Patricia Manuela Ribeiro Pereira · Washington University · R37 · FY2023 · CA
Fruit and vegetable intervention in lactating women to reduce breast cancer risk: effects on breast cell DNA methylation, breast inflammation, and weight
$633,809Kathleen Frances Arcaro · University Of Massachusetts Amherst · R01 · FY2019 · CA
DEVELOPMENT OF GOGGLE SYSTEM FOR FLUORESCENCE IMAGE-GUIDED SURGERY
$633,775Samuel Achilefu · Washington University · R01 · FY2013 · CA
INTERPLAY BETWEEN SENSORY NEURONS AND NK CELLS DURING BREAST CANCER METASTATIC DORMANCY
$633,750Icahn School Of Medicine At Mount Sinai · · FY2025 · Defense Health Agency
INTERPLAY BETWEEN SENSORY NEURONS AND NK CELLS DURING BREAST CANCER METASTATIC DORMANCY
$633,750Icahn School Of Medicine At Mount Sinai · · FY2025 · Defense Health Agency
Caregiver Coping Skills training for Lung Cancer
$633,747Duke University · R01 · FY2003 · CA
Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA
$633,738Miriam C Poirier · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Administrative Core
$633,675Haifa Shen · Methodist Hospital Research Institute · U54 · FY2019 · CA
High Throughput Screening to Discover Chemical Inhibitors of Quiescin Sulfhydryl Oxidase 1
$633,669Douglas Faigel · Mayo Clinic Arizona · R01 · FY2016 · CA
Reversing Drug Resistance in Tumors with Clickable Antibody Pairs
$633,658Patricia Manuela Ribeiro Pereira · Washington University · R37 · FY2025 · CA
Chemical Probes for Metabolic Pathway Discovery in Human Disease
$633,635Benjamin F Cravatt · Scripps Research Institute, The · R01 · FY2007 · CA
Primary Prevention to Reduce Cardiovascular Morbidity and Optimize Cancer Outcomes
$633,608Aniket A Kawatkar · Kaiser Foundation Research Institute · R01 · FY2025 · HL
Hemopexin as an Early Biomarker of Anthracycline Cardiac Toxicity
$633,596Aarti Asnani · Beth Israel Deaconess Medical Center · R01 · FY2024 · HL
Receptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept
$633,492Frederick Oliver Cope · Navidea Biopharmaceuticals, Inc. · R44 · FY2016 · CA
Population Modeling of Bladder Cancer Detection and Control
$633,411Thomas Trikalinos · Brown University · U01 · FY2024 · CA
Bladder cancer PD-L1 control of homologous recombination: Basic mechanisms applied to novel treatments
$633,409Tyler J. Curiel · Dartmouth-Hitchcock Clinic · R01 · FY2025 · CA
A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial
$633,405Tamara J Somers · Duke University · R01 · FY2020 · CA
Targeting Siglec-9/Sialoglycan Interactions to Enhance NK Functions During HIV Infection
$633,402Mohamed Abdel Mohsen · Wistar Institute · R01 · FY2023 · AI
Machine learning drives translational research from drug interactions to pharmacogenetics
$633,396Lang Li · Ohio State University · R01 · FY2023 · LM
Site-specific Integration of Large (10-100 kb) DNA Constructs into the Mouse Genome and Human Induced Pluripotent Stem Cells Using the Cas9-Bxb1 Integrase Toolbox
$633,395Vishnu Hosur · Jackson Laboratory · R01 · FY2023 · CA
Sustaining antitumor effector CD8+ T cells for cancer therapy
$633,355Bin Zhang · Northwestern University At Chicago · R01 · FY2024 · CA